ACOG logo

ACOG
Alpha Cognition Inc

359
Mkt Cap
$129.55M
Volume
24,716.00
52W High
$11.54
52W Low
$4.50
PE Ratio
-5.06
ACOG Fundamentals
Price
$5.76
Prev Close
$5.95
Open
$5.85
50D MA
$6.07
Beta
0.91
Avg. Volume
61,529.12
EPS (Annual)
-$1.18
P/B
2.07
Rev/Employee
$143,947.54
$48.82
Loading...
Loading...
News
all
press releases
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Wall Street Zen Downgrades Alpha Cognition (NASDAQ:ACOG) to Sell
Wall Street Zen downgraded Alpha Cognition from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·13d ago
News Placeholder
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its first quarter 2026 financial...
Business Wire·16d ago
News Placeholder
Alpha Cognition (NASDAQ:ACOG) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $18.00 target price on shares of Alpha Cognition in a research report on Monday...
MarketBeat·17d ago
News Placeholder
Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences
Alpha Cognition, Inc. (NASDAQ: ACOG) (Alpha Cognition, ACI, or the Company), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced...
Business Wire·17d ago
News Placeholder
Short Interest in Alpha Cognition Inc. (NASDAQ:ACOG) Drops By 37.3%
Alpha Cognition Inc. (NASDAQ:ACOG - Get Free Report) was the recipient of a large drop in short interest during the month of April. As of April 15th, there was short interest totaling 205,331 shares...
MarketBeat·17d ago
News Placeholder
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
Alpha Cognition Inc. (Nasdaq: ACOG) (Alpha Cognition, or the Company), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Bethany Sensenig to its Board of Directors, effective April 15, 2026. Ms...
Business Wire·24d ago
News Placeholder
Alpha Cognition (NASDAQ:ACOG) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded Alpha Cognition from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·27d ago
News Placeholder
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alpha Cognition Inc. (NASDAQ: ACOG) (Alpha Cognition, ACI, or the Company), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced...
Business Wire·29d ago
News Placeholder
Alpha Cognition Q1 EPS Forecast Decreased by HC Wainwright
Alpha Cognition Inc. (NASDAQ:ACOG - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 EPS estimates for Alpha Cognition in a research report issued on Wednesday, April 8th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($0.28) per share for the qu...
MarketBeat·1mo ago
<
1
2
...
>

Latest ACOG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.